Navigation Links
Genetic And Microbiome Discoveries Point The Way To New Treatments For Crohn's & Colitis Patients
Date:7/18/2014

NEW YORK, July 18, 2014 /PRNewswire-USNewswire/ -- High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal:  developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.

It's fundraising programs like Take Steps, the Foundation's national walk program dedicated to raising funds for critical research and increasing awareness of Crohn's disease and ulcerative colitis, that are driving forces behind the advancements that have been made in IBD research.  "We anticipate that in the next three to five years, we will identify novel genetic and microbial targets that will form the basis for new therapeutic interventions," said Caren Heller, MD, MBA, Chief Scientific Officer, the Crohn's & Colitis Foundation of America. 

Now in its seventh year, Take Steps is gearing up for its Fall walk season with over 45 walks scheduled across the country.  Take Steps walks are family friendly festivals with activities for everyone including games, music, and great food.  "We're here to provide hope and support for the 1.4 million Americans affected by Crohn's and colitis," said Rick Geswell, President & CEO of the Crohn's & Colitis Foundation of America.   "We are grateful for everyone who helps raise awareness and crucial funds through programs like Take Steps and I assure you that all money raised is used wisely, with 82 cents of every dollar spent going toward groundbreaking research, patient and professional education, and patient support programs, " said Geswell. 

About Crohn's Disease and Ulcerative Colitis
Known collectively as inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis affects 1 in 200 people.  They are painful, medically incurable diseases that attack the digestive system. Crohn's disease may attack anywhere along the digestive tract, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, persistent diarrhea, rectal bleeding, fever and weight loss. Many patients require numerous hospitalizations and surgery.  Most people develop the diseases between the ages of 15 and 35; however the incidence is increasing in children.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America (CCFA) is the largest voluntary non-profit health organization dedicated to finding cures for Inflammatory Bowel Diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research, providing educational resources for patients and their families, medical professionals, and the public, and furnishing supportive services for those afflicted with IBD. For more information, visit www.ccfa.org, call 888-694-8872, join us on Facebook at www.facebook.com/ccfafb and www.facebook.com/ccfatakesteps, or follow CCFA and Take Steps on Twitter at www.twitter.com/ccfa and www.twitter.com/takesteps.

Video - https://www.youtube.com/watch?v=rXs4IsGqp5k
Video - https://www.youtube.com/watch?v=rP4zU5QE1Hc


'/>"/>
SOURCE Crohn's & Colitis Foundation of America
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. QIAGEN and Exosome Diagnostics to Develop First-In-Class, Non-Invasive Diagnostics for Key Genetic Biomarkers in Lung and Other Cancers
2. InformedDNA Partners with Three New Cancer Centers to Provide Genetic Counseling
3. Potential Acquisitions and Stock Price Updates - Research Report on BioMarin, Covidien, United Therapeutics, Brookdale, and Seattle Genetics
4. Sharp Edge Labs and SpectraGenetics Sign Agreement to Provide Better Assays for Studying G-Protein Coupled Receptors
5. New Guidelines Released for Diagnosis, Surveillance and Management of Rare Genetic Disease Called Tuberous Sclerosis Complex
6. Investigación internacional: Compartir mejor la información genética en la salud humana
7. Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
8. Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimers Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
9. Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
10. Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic
11. A Finnish Company Enters International Markets With World Class Genetics Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... -- ... Washington DC ... 12 th – Monday, September 18 th .The Brain Tumor Foundation ... scans to the public.Where:  BTF,s Mobile MRI Unit ... Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/6/2017)... Sept. 6, 2017  Medical professionals are ... skills while treating their patients. Medical simulations ... without involving patients. Simulation provides a safe ... carry out procedures, refine techniques and build ... of new technology, such as augmented reality, ...
Breaking Medicine Technology:
(Date:9/26/2017)... ... September 26, 2017 , ... Atmosera , a premier ... as a Service (RMaaS) to automate the deployment of websites and applications ... e-tailers, and web development agencies who want to improve time-to-revenue with a reliable, ...
(Date:9/26/2017)... Barcelona, Spain (PRWEB) , ... September 26, 2017 ... ... exciting nutritional ingredient that is not only entirely new and different, it is ... extracts, announced today that the company has received an exclusive license agreement with ...
(Date:9/26/2017)... ... September 26, 2017 , ... After ... R. Elliott HERO Campaign for Designated Drivers proudly announced the winners of the ... local bars and restaurants took on the challenge of competing in three categories: ...
(Date:9/26/2017)... ... September 26, 2017 , ... Data Integrity: , The Key ... Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity , Consider ... the firm’s electronic records may not be trustworthy and reliable … a more detailed ...
(Date:9/26/2017)... ... September 26, 2017 , ... Dr. Kovatis, ... of the Leg, Ankle, and Foot Section of the Department of Orthopedic Surgery ... orthopedic surgeon at Hackensack UMC performing total ankle replacements. Because of this, Dr. ...
Breaking Medicine News(10 mins):